ArticleBMC oral health2026
Age-specific reference values for unstimulated whole saliva flow rate in primary Sjögren's syndrome: a cross-sectional study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe clinical phenotype of primary Sjögren's syndrome (pSS) varies with age at onset, yet evidence on age and unstimulated whole saliva (UWS) flow rate in pSS is limited and conflicting. This study describes the age-specific distribution of UWS flow rate in pSS patients and provides reference values for clinical use.
methodsThis retrospective cross-sectional study included pSS patients diagnosed per 2016 ACR/EULAR criteria, stratified by age at diagnosis: early-onset (≤ 35 years), middle-onset (35-65 years), and elderly-onset (≥ 65 years). UWS flow rate was compared across groups. Linear regression assessed the age-UWS association, adjusting for sex, pre-diagnostic period, and anticholinergic use. For each age group, we calculated the 5th, 25th, 50th, 75th, and 95th percentiles of UWS flow rate as reference values.
resultsOf 338 pSS patients (early-onset ≤ 35 years: 40; middle-onset 35-65 years: 193; elderly-onset ≥ 65 years: 105), UWS flow rate decreased significantly with age. Each 10-year increase was associated with a 0.04 mL/min decrease (β= -0.04, 95% CI: -0.06 to -0.03, P < 0.001), independent of sex, pre-diagnostic period, and anticholinergic use. The median UWS flow rate was 0.29[0.20-0.47] mL/min in the early-onset group, 0.20[0.10-0.39] mL/min in the middle-onset group, and 0.14[0.05-0.22] mL/min in the elderly-onset group, with significant differences between early- and middle-onset (P = 0.013) and between middle- and elderly-onset (P < 0.001). Age-specific percentiles were established as reference values.
conclusionUWS flow rate in pSS patients declines with age, independent of confounders. The age-specific reference values provided herein facilitate longitudinal monitoring and interpretation of UWS measurements in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.